Kwality Pharmaceuticals Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

900.10 +12.10 (1.36%)Updated : 05 Dec 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	447.27	394.21	353.63	340.59
Accumulated Depreciation Total	-85.29	-67.03	-	-
Cash Equivalents	2.74	3.69	7.36	12.95
Other Liabilities Total	0.25	0.22	0.90	0.75
Accrued Expenses	0.16	0.19	-	-
Long Term Debt	15.12	19.56	27.30	20.29
Common Stock Total	10.38	10.38	10.38	10.38
Other Current Assets Total	12.80	19.03	31.48	67.18
Total Assets	447.27	394.21	353.63	340.59
Current Portof LT Debt/ Capital Leases	13.99	12.54	-	-
Additional Paid- In Capital	8.47	8.47	-	-
Cash	12.02	2.26	-	-
Total Equity	264.05	224.21	200.52	181.14
Long Term Investments	0.00	0.00	0.00	0.00
Retained Earnings( Accumulated Deficit)	244.40	204.60	190.14	170.77
Total Common Shares Outstanding	1.04	1.04	1.04	1.04
Property/ Plant/ Equipment Total- Gross	228.04	205.21	-	-
Tangible Book Valueper Share Common Eq	252.83	216.08	193.25	174.58
Total Liabilities	183.22	170.00	153.12	159.45
Total Debt	112.45	98.12	90.26	54.01
Cashand Short Term Investments	14.76	5.94	7.36	12.95
Total Receivables Net	164.85	127.13	82.04	94.33
Notes Payable/ Short Term Debt	83.33	66.02	62.96	33.72
Deferred Income Tax	0.00	0.00	0.41	0.27
Accounts Receivable- Trade Net	154.31	114.39	71.69	69.13
Property/ Plant/ Equipment Total- Net	143.98	139.05	134.79	103.88
Minority Interest	-1.65	-1.63	-1.45	-1.35
Total Current Liabilities	169.51	151.85	125.95	139.49
Total Inventory	91.38	90.59	86.31	53.36
Accounts Payable	55.79	44.32	35.19	34.51
Other Currentliabilities Total	16.22	28.78	27.79	71.25
Total Long Term Debt	15.12	19.56	27.30	20.29
Intangibles Net	1.71	-	-	-
Other Long Term Assets Total	6.27	1.09	11.64	8.89
Note Receivable- Long Term	11.53	11.38	-	-
Unrealized Gain( Loss)	0.80	0.80	-	-
period Length	0.00	0.00	0.00	0.00
Total Current Assets	283.78	242.69	207.20	227.82
Other Equity Total	-	-0.04	-	-